268 related articles for article (PubMed ID: 21467230)
21. Exposure and Metabolic Activation Biomarkers of Carcinogenic Tobacco-Specific Nitrosamines.
Hecht SS; Stepanov I; Carmella SG
Acc Chem Res; 2016 Jan; 49(1):106-14. PubMed ID: 26678241
[TBL] [Abstract][Full Text] [Related]
22. Exposure to a tobacco-specific lung carcinogen in adolescent versus adult smokers.
Hertsgaard LA; Hanson K; Hecht SS; Lindgren BR; Luo X; Carmella SG; Riley WT; Zylla EB; Murphy SE; Hatsukami DK
Cancer Epidemiol Biomarkers Prev; 2008 Dec; 17(12):3337-43. PubMed ID: 19064548
[TBL] [Abstract][Full Text] [Related]
23. 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol and its glucuronides in the urine of infants exposed to environmental tobacco smoke.
Hecht SS; Carmella SG; Le KA; Murphy SE; Boettcher AJ; Le C; Koopmeiners J; An L; Hennrikus DJ
Cancer Epidemiol Biomarkers Prev; 2006 May; 15(5):988-92. PubMed ID: 16702381
[TBL] [Abstract][Full Text] [Related]
24. A tobacco-specific lung carcinogen in the urine of men exposed to cigarette smoke.
Hecht SS; Carmella SG; Murphy SE; Akerkar S; Brunnemann KD; Hoffmann D
N Engl J Med; 1993 Nov; 329(21):1543-6. PubMed ID: 8413477
[TBL] [Abstract][Full Text] [Related]
25. Children's exposure to environmental tobacco smoke: using diverse exposure metrics to document ethnic/racial differences.
Sexton K; Adgate JL; Church TR; Hecht SS; Ramachandran G; Greaves IA; Fredrickson AL; Ryan AD; Carmella SG; Geisser MS
Environ Health Perspect; 2004 Mar; 112(3):392-7. PubMed ID: 14998759
[TBL] [Abstract][Full Text] [Related]
26. Hand nicotine as an independent marker of thirdhand smoke pollution in children's environments.
Mahabee-Gittens EM; Merianos AL; Stone L; Wullenweber CA; Quintana PJE; Hoh E; Dodder NG; Lopez-Galvez N; Matt GE
Sci Total Environ; 2022 Nov; 849():157914. PubMed ID: 35952873
[TBL] [Abstract][Full Text] [Related]
27. Metabolites of a tobacco-specific lung carcinogen in nonsmoking casino patrons.
Anderson KE; Kliris J; Murphy L; Carmella SG; Han S; Link C; Bliss RL; Puumala S; Murphy SE; Hecht SS
Cancer Epidemiol Biomarkers Prev; 2003 Dec; 12(12):1544-6. PubMed ID: 14693752
[TBL] [Abstract][Full Text] [Related]
28. Metabolites of a tobacco-specific carcinogen in urine from newborns.
Lackmann GM; Salzberger U; Töllner U; Chen M; Carmella SG; Hecht SS
J Natl Cancer Inst; 1999 Mar; 91(5):459-65. PubMed ID: 10070946
[TBL] [Abstract][Full Text] [Related]
29. Urine concentrations of a tobacco-specific nitrosamine carcinogen in the U.S. population from secondhand smoke exposure.
Bernert JT; Pirkle JL; Xia Y; Jain RB; Ashley DL; Sampson EJ
Cancer Epidemiol Biomarkers Prev; 2010 Nov; 19(11):2969-77. PubMed ID: 20833972
[TBL] [Abstract][Full Text] [Related]
30. Exposure to the carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers from 3 populations with different risks of lung cancer.
Derby KS; Cuthrell K; Caberto C; Carmella S; Murphy SE; Hecht SS; Le Marchand L
Int J Cancer; 2009 Nov; 125(10):2418-24. PubMed ID: 19598261
[TBL] [Abstract][Full Text] [Related]
31. Thirdhand tobacco smoke: a tobacco-specific lung carcinogen on surfaces in smokers' homes.
Thomas JL; Hecht SS; Luo X; Ming X; Ahluwalia JS; Carmella SG
Nicotine Tob Res; 2014 Jan; 16(1):26-32. PubMed ID: 23892827
[TBL] [Abstract][Full Text] [Related]
32. Carcinogen derived biomarkers: applications in studies of human exposure to secondhand tobacco smoke.
Hecht SS
Tob Control; 2004 Mar; 13 Suppl 1(Suppl 1):i48-56. PubMed ID: 14985617
[TBL] [Abstract][Full Text] [Related]
33. Intraindividual and interindividual differences in metabolites of the tobacco-specific lung carcinogen 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanone (NNK) in smokers' urine.
Carmella SG; Akerkar SA; Richie JP; Hecht SS
Cancer Epidemiol Biomarkers Prev; 1995 Sep; 4(6):635-42. PubMed ID: 8547830
[TBL] [Abstract][Full Text] [Related]
34. Uptake and metabolism of carcinogenic levels of tobacco-specific nitrosamines by Sudanese snuff dippers.
Murphy SE; Carmella SG; Idris AM; Hoffmann D
Cancer Epidemiol Biomarkers Prev; 1994; 3(5):423-8. PubMed ID: 7920210
[TBL] [Abstract][Full Text] [Related]
35. Assessment of tobacco specific nitrosamines (TSNAs) in oral fluid as biomarkers of cancer risk: A population-based study.
Pérez-Ortuño R; Martínez-Sánchez JM; Fu M; Ballbè M; Quirós N; Fernández E; Pascual JA
Environ Res; 2016 Nov; 151():635-641. PubMed ID: 27619208
[TBL] [Abstract][Full Text] [Related]
36. Tobacco-specific nitrosamine 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol (NNAL) in smokers in the United States: NHANES 2007-2008.
Xia Y; Bernert JT; Jain RB; Ashley DL; Pirkle JL
Biomarkers; 2011 Mar; 16(2):112-9. PubMed ID: 21114376
[TBL] [Abstract][Full Text] [Related]
37. Effects of reduced cigarette smoking on the uptake of a tobacco-specific lung carcinogen.
Hecht SS; Murphy SE; Carmella SG; Zimmerman CL; Losey L; Kramarczuk I; Roe MR; Puumala SS; Li YS; Le C; Jensen J; Hatsukami DK
J Natl Cancer Inst; 2004 Jan; 96(2):107-15. PubMed ID: 14734700
[TBL] [Abstract][Full Text] [Related]
38. Tobacco-specific nitrosamine exposures in smokers and nonsmokers exposed to cigarette or waterpipe tobacco smoke.
Radwan G; Hecht SS; Carmella SG; Loffredo CA
Nicotine Tob Res; 2013 Jan; 15(1):130-8. PubMed ID: 22573723
[TBL] [Abstract][Full Text] [Related]
39. Subpicogram per milliliter determination of the tobacco-specific carcinogen metabolite 4-(methylnitrosamino)-1-(3-pyridyl)-1-butanol in human urine using liquid chromatography-tandem mass spectrometry.
Jacob P; Havel C; Lee DH; Yu L; Eisner MD; Benowitz NL
Anal Chem; 2008 Nov; 80(21):8115-21. PubMed ID: 18841944
[TBL] [Abstract][Full Text] [Related]
40. Effect of differing levels of tobacco-specific nitrosamines in cigarette smoke on the levels of biomarkers in smokers.
Ashley DL; O'Connor RJ; Bernert JT; Watson CH; Polzin GM; Jain RB; Hammond D; Hatsukami DK; Giovino GA; Cummings KM; McNeill A; Shahab L; King B; Fong GT; Zhang L; Xia Y; Yan X; McCraw JM
Cancer Epidemiol Biomarkers Prev; 2010 Jun; 19(6):1389-98. PubMed ID: 20501750
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
